A long and winding road; evolution of antimicrobial drug development – crisis management

2012 ◽  
Vol 10 (11) ◽  
pp. 1311-1319 ◽  
Author(s):  
Roger M Echols
2018 ◽  
Vol 46 (S1) ◽  
pp. 50-58 ◽  
Author(s):  
Gregory W. Daniel ◽  
Monika Schneider ◽  
Marianne Hamilton Lopez ◽  
Mark B. McClellan

As part of a multifactorial approach to address weak incentives for innovative antimicrobial drug development, market entry rewards (MERs) are an emerging solution. Recently, the Duke-Margolis Center for Health Policy released the Priority Antimicrobial Value and Entry (PAVE) Award proposal, which combines a MER with payment reforms, transitioning from volume-based to “value-based” payments for antimicrobials. Here, the PAVE Award and similar MERs are reviewed, focusing on further refinement and avenues for implementation.


Author(s):  
Лачкова Людмила ◽  
Борисова Аліна ◽  
Лачкова Вікторія

The article deals with methodical approaches to the formation of the anti- crisis program of trade enterprises and drawing up of a plan for its implementation. During the research, it was determined that the basis of the crisis management program is diagnostics of the enterprise's development crisis, which should include not only probability of the enterprise bankruptcy, but also determine the existence of internal reserves of confrontation against it. In order to generalize and systematically present the developed anti-crisis measures and expected results after their implementation, it is proposed to use the methodology of problem structuring of the anti-crisis program and the schedule of their achievement, which contributed to the implementation of effective crisis management in trade enterprises.


2004 ◽  
Vol 38 (9) ◽  
pp. 1279-1286 ◽  
Author(s):  
B. Spellberg ◽  
J. H. Powers ◽  
E. P. Brass ◽  
L. G. Miller ◽  
J. E. Edwards

2016 ◽  
Vol 509 ◽  
pp. 89-91 ◽  
Author(s):  
Pushpanathan Muthirulan ◽  
Arun Richard Chandrasekaran

Sign in / Sign up

Export Citation Format

Share Document